We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$33.6B
AUM Growth
-$258M
Cap. Flow
-$892M
Cap. Flow %
-2.66%
Top 10 Hldgs %
9.6%
Holding
1,511
New
98
Increased
472
Reduced
496
Closed
89

Top Buys

Rank Stock Value
1
NUS icon
Nu Skin
NUS
+$123M
2
DAN icon
Dana Inc
DAN
+$61.6M
3
BRCD
Brocade Communications Systems, Inc. NEW
BRCD
+$55.3M
4
CVEO icon
Civeo
CVEO
+$37.3M
5
PLUS icon
ePlus
PLUS
+$30M

Sector Composition

Rank Sector Weight
1 Industrials 24.45%
2 Technology 18.1%
3 Consumer Discretionary 14.79%
4 Financials 9.92%
5 Materials 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNT
1
DELISTED
UNIT Corporation
UNT
$401M 1.19%
5,822,122
-280,201
-5% -$18.3M
THO icon
2
Thor Industries
THO
$3.97B
$389M 1.16%
6,839,182
-427,640
-6% -$25.6M
MYGN icon
3
Myriad Genetics
MYGN
$304M
$362M 1.08%
9,299,478
-136,235
-1% -$5.07M
FHI icon
4
Federated Hermes
FHI
$4.84B
$350M 1.04%
11,306,220
-1,144,044
-9% -$33.3M
BKE icon
5
Buckle
BKE
$2.21B
$341M 1.02%
7,691,625
+16,996
+0.2% +$776K
RS icon
6
Reliance Steel & Aluminium
RS
$20B
$339M 1.01%
4,602,672
-826,940
-15% -$59.4M
VMI icon
7
Valmont Industries
VMI
$9.28B
$271M 0.81%
1,783,055
+128,015
+8% +$19.7M
MKSI icon
8
MKS Inc
MKSI
$18.3B
$259M 0.77%
8,297,924
+278,924
+3% +$8.08M
NUS icon
9
Nu Skin
NUS
$233M
$257M 0.77%
3,481,539
+1,557,616
+81% +$123M
Y
10
DELISTED
Alleghany Corp
Y
$255M 0.76%
582,313
+800
+0.1% +$334K
POLY
11
DELISTED
Plantronics, Inc.
POLY
$254M 0.76%
5,285,850
+368,041
+7% +$16.4M
UNF icon
12
Unifirst Corp
UNF
$5.17B
$242M 0.72%
2,280,800
+5,450
+0.2% +$538K
MTX icon
13
Minerals Technologies
MTX
$2.25B
$242M 0.72%
3,683,702
-334,647
-8% -$20.9M
LECO icon
14
Lincoln Electric
LECO
$15.8B
$241M 0.72%
3,442,439
-209,814
-6% -$14.2M
WWD icon
15
Woodward
WWD
$20.4B
$233M 0.69%
4,638,524
RBA icon
16
RB Global
RBA
$15.9B
$226M 0.67%
9,163,367
+115,000
+1% +$2.74M
KW
17
DELISTED
Kennedy-Wilson Holdings
KW
$219M 0.65%
8,183,160
+314,800
+4% +$7.51M
WLK icon
18
Westlake Corp
WLK
$9.45B
$218M 0.65%
2,599,035
-590,401
-19% -$44.2M
PAAS icon
19
Pan American Silver
PAAS
$22.8B
$216M 0.64%
14,059,803
+1,238,700
+10% +$16.4M
AVX
20
DELISTED
AVX Corporation
AVX
$215M 0.64%
16,152,631
+640,847
+4% +$8.5M
MATV icon
21
Mativ Holdings
MATV
$672M
$213M 0.63%
4,873,919
+201,968
+4% +$8.49M
AIT icon
22
Applied Industrial Technologies
AIT
$12.4B
$209M 0.62%
4,110,405
+321,724
+8% +$15.5M
CGNX icon
23
Cognex
CGNX
$10.6B
$200M 0.59%
10,402,408
-100,000
-1% -$1.77M
NATI
24
DELISTED
National Instruments Corp
NATI
$196M 0.58%
6,044,551
+50,000
+0.8% +$1.44M
MDCO
25
DELISTED
Medicines Co
MDCO
$193M 0.58%
6,656,025
+540,825
+9% +$14.4M

Similar funds

Royce & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Royce & Associates held 1,511 positions worth $33.6B, down 0.76% from $33.9B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Royce & Associates's Q2 2014 filing shows 98 new, 472 increased, 496 reduced and 89 closed positions. Its largest new stake was Civeo: 124,691 shares worth $37.5M. The largest sale was Zebra Technologies, an estimated $107M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Royce & Associates's largest Q2 2014 buy was Civeo: 124,691 shares worth $37.5M.
  • Royce & Associates added most to Nu Skin in Q2 2014, an estimated $123M increase.
  • Royce & Associates's biggest Q2 2014 reduction was Zebra Technologies, cutting an estimated $107M.
  • Royce & Associates fully exited Entegris in Q2 2014, selling an estimated $35.5M.
  • Royce & Associates's ten largest holdings make up 9.6% of its $33.6B portfolio in Q2 2014.
  • Royce & Associates opened 98 new positions and closed 89 in Q2 2014.
  • Royce & Associates's portfolio value fell 0.76% quarter-over-quarter to $33.6B.

Based on Royce & Associates's 13F filing for Q2 2014, filed 11 Aug 2014.